Illustration: Aïda Amer/Axios

Somewhat forgotten in the evaluation of the current state of the U.S. economy is the ongoing debacle at Boeing, a flagship American company whose production shutdown led to the New York Fed estimating it would shave 20% off of 2020's GDP growth — and this was before the coronavirus outbreak. Things could be getting worse for Boeing.

Driving the news: A report is due this week from airline safety investigators to coincide with the one-year anniversary of the Ethiopian Airlines crash that was the second in six months for Boeing's 737 MAX jets.

  • On Friday, the House Transportation and Infrastructure Committee released its report outlining a laundry list of Boeing's reckless and unforced errors that led to the two plane crashes and the deaths of 346 people.
  • Over the weekend, co-CEO Dave Calhoun backtracked from a scathing New York Times interview bashing his predecessor that could land him and more top execs in front of lawmakers for congressional hearings.

Why it matters: Boeing is the largest manufacturing exporter in the U.S. and a major employer. Its products cost hundreds of millions of dollars and require thousands of suppliers, some of whom count Boeing as their sole client.

  • Boeing had to reduce production last year amid a recession in U.S. manufacturing and declining business investment that economists and industry insiders expected to bounce back this year.
  • The Council of Economic Advisers estimated that the slowdown cut U.S. GDP in Q2 2019 by 0.4 percentage points, so its outright production halt through Q1 2020 and possibly longer could deliver a much worse financial shock.

What's happening: Friday’s congressional report detailed Boeing’s efforts to avoid putting pilots through flight-simulator training to save money, and alleged that the company's penny-pinching was pervasive, stretching across engineering, marketing and management.

  • The report said this resulted in the company misleading or withholding information from FAA officials.
  • Both crashes occurred after pilots were unable to undo the automated flight-control feature that they were supposed to be trained on when it misfired repeatedly and pushed down the nose of their plane leading to the crash, WSJ reported.

The bottom line: The U.S. economy needs Boeing to get back on its feet, but the widespread malfeasance detailed in the report could mean it stays grounded for even longer as a further spate of government hearings and investigations unfold.

Go deeper: New Boeing CEO criticizes predecessor, looks to future

Go deeper

16 mins ago - World

Nuclear free-for-all: The arms control era may be ending

Illustration: Aïda Amer/Axios

The mushroom clouds over Hiroshima and Nagasaki have remained unreplicated for 75 years in part because the U.S. and Soviet Union — after peering over the ledge into nuclear armageddon — began to negotiate.

Why it matters: The arms control era that began after the Cuban Missile Crisis may now be coming to a close. The next phase could be a nuclear free-for-all.

Pelosi, Schumer demand postmaster general reverse USPS cuts ahead of election

Schumer and Pelosi. Photo: Alex Wong/Getty Images

House Speaker Nancy Pelosi (D-Calif.) and Senate Minority Leader Chuck Schumer sent a letter to Postmaster General Louis DeJoy on Thursday calling for the recent Trump appointee to reverse operational changes to the U.S. Postal Service that "threaten the timely delivery of mail" ahead of the 2020 election.

Why it matters: U.S. mail and election infrastructure are facing a test like no other this November, with a record-breaking number of mail-in ballots expected as Americans attempt to vote in the midst of a pandemic.

2 hours ago - Science

CRISPR co-discoverer on the gene editor's pandemic push

Photo illustration: Aïda Amer/Axios. Photos: Brian Ach/Getty Images for Wired and BSIP/UIG via Getty Images

The coronavirus pandemic is accelerating the development of CRISPR-based tests for detecting disease — and highlighting how gene-editing tools might one day fight pandemics, one of its discoverers, Jennifer Doudna, tells Axios.

Why it matters: Testing shortages and backlogs underscore a need for improved mass testing for COVID-19. Diagnostic tests based on CRISPR — which Doudna and colleagues identified in 2012, ushering in the "CRISPR revolution" in genome editing — are being developed for dengue, Zika and other diseases, but a global pandemic is a proving ground for these tools that hold promise for speed and lower costs.